News & Events

Ridgeview Announces Partnership with Twin Cities-Based OneOme, Provider of RightMed® Test

Patients to Benefit from Personalized Prescription Treatment Options

Waconia, Minn. (Dec. 5, 2016) – Driven to continually improve patient care, Ridgeview Medical Center today announced a partnership with Twin Cities-based pharmacogenomics company OneOme, developer of the RightMed test. Through this partnership, Ridgeview patients will have an opportunity to receiv...


CEOCFO Magazine: Revolutionary prescription writing and ordering portal based on a patient’s genetic profile allows physicians to provide more personalized medications

CEOCFO Magazine, a “weekly publication featuring in-depth interviews with many of today’s top corporate executives,” recently published an interview with Paul Owen, CEO of OneOme.

In the interview Paul discusses the OneOme RightMed® pharmacogenomic test, an analysis of individual patients’...


Pharmacy Executive Joins OneOme

Harlan Langstraat, R.Ph., Will Assist in Business Development for Pharmacy-Related Partnerships

MINNEAPOLIS (Nov. 30, 2016) – Pharmacogenomics company OneOme announced the addition of Harlan Langstraat, R.Ph., to its growing organization. Langstraat has joined OneOme to assist in business development activities.

Langstraat’s career has included senior management positions in both for-pro...


Minnesota Company Launches an Innovative Approach to Identifying Personalized Prescriptions

OneOme Introduces the RightMed® Test to Personalize Medications, Based on Each Patient’s Own Genetic Makeup

MINNEAPOLIS (Nov. 29, 2016) – A Minnesota company today announced it has launched an innovative physician-ordered test for identifying which medications may work best for individual patients. OneOme, a growing pharmacogenomics company, has introduced the RightMed test, making it possible for physi...


OneOme Moves to Expand PGx Business Beyond Mayo Clinic With New PCR-Based Panel

NEW YORK (GenomeWeb) – After more than a year building its business as a provider of pharmacogenomic data interpretation, PGx firm OneOme has now expanded with the launch of its own genetic test, a PCR-based panel covering 22 genes related to hundreds of drugs.

Download full article